Xeris Biopharma Holdings (XERS) Earnings Date & Reports

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

XERS is expected to report earnings to fall 77.33% to 1 cents per share on August 06

Xeris Biopharma Holdings XERS Stock Earnings Reports

Q2'26

Est.

$0.01

Q4'25

Beat

by $0.04

Q3'25

Missed

by $0.01

Q2'25

Beat

by $0.02

Q1'25

Missed

by $0.01

The last earnings report on March 02 showed earnings per share of 5 cents, beating the estimate of 1 cents. With 322.75K shares outstanding, the current market capitalization sits at 1.19B.

View a ticker or compare two or three

Compare

XERS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for XERS